Literature DB >> 18567839

Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.

Peter N Lalli1, Michael G Strainic, Min Yang, Feng Lin, M Edward Medof, Peter S Heeger.   

Abstract

Our recent studies have shown that immune cell-produced complement provides costimulatory and survival signals to naive CD4(+) T cells. Whether these signals are similarly required during effector cell expansion and what molecular pathways link locally produced complement to T-cell survival were not clarified. To address this, we stimulated monoclonal and polyclonal T cells in vitro and in vivo with antigen-presenting cells (APCs) deficient in the complement regulatory protein, decay accelerating factor (DAF), and/or the complement component C3. We found that T-cell expansion induced by DAF-deficient APCs was augmented with diminished T-cell apoptosis, whereas T-cell expansion induced by C3(-/-) APCs was reduced because of enhanced T-cell apoptosis. These effects were traced to locally produced C5a, which through binding to T cell-expressed C5aR, enhanced expression of Bcl-2 and prevented Fas up-regulation. The results show that C5aR signal transduction in T cells is important to allow optimal T-cell expansion, as well as to maintain naive cell viability, and does so by suppressing programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567839      PMCID: PMC2518884          DOI: 10.1182/blood-2008-04-151068

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  In vivo regulation of neutrophil apoptosis by C5a during sepsis.

Authors:  Ren-Feng Guo; Lei Sun; Hongwei Gao; Kevin X Shi; Daniel Rittirsch; Vidya J Sarma; Firas S Zetoune; Peter A Ward
Journal:  J Leukoc Biol       Date:  2006-09-22       Impact factor: 4.962

2.  Human T cells express the C5a receptor and are chemoattracted to C5a.

Authors:  S Nataf; N Davoust; R S Ames; S R Barnum
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

3.  Cutting Edge: Limiting amounts of IL-7 do not control contraction of CD4+ T cell responses.

Authors:  Pulak Tripathi; Thomas C Mitchell; Fred Finkelman; David A Hildeman
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

4.  Bim mediates apoptosis of CD127(lo) effector T cells and limits T cell memory.

Authors:  Sara Wojciechowski; Michael B Jordan; Yanan Zhu; Janice White; Allan J Zajac; David A Hildeman
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

Review 5.  Life and death in peripheral T cells.

Authors:  Peter H Krammer; Rüdiger Arnold; Inna N Lavrik
Journal:  Nat Rev Immunol       Date:  2007-07       Impact factor: 53.106

6.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

7.  Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.

Authors:  Peter B Stranges; Jessica Watson; Cristie J Cooper; Caroline-Morgane Choisy-Rossi; Austin C Stonebraker; Ryan A Beighton; Heather Hartig; John P Sundberg; Stein Servick; Gunnar Kaufmann; Pamela J Fink; Alexander V Chervonsky
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

8.  The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo.

Authors:  Jianuo Liu; Takashi Miwa; Brendan Hilliard; Youhai Chen; John D Lambris; Andrew D Wells; Wen-Chao Song
Journal:  J Exp Med       Date:  2005-02-14       Impact factor: 14.307

9.  Decay-accelerating factor modulates induction of T cell immunity.

Authors:  Peter S Heeger; Peter N Lalli; Feng Lin; Anna Valujskikh; Jinbo Liu; Nasima Muqim; Yuanyuan Xu; M Edward Medof
Journal:  J Exp Med       Date:  2005-05-09       Impact factor: 14.307

10.  Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

Authors:  M E Medof; T Kinoshita; V Nussenzweig
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  138 in total

1.  Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis.

Authors:  Markus Bosmann; J Vidya Sarma; Gelareh Atefi; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2011-12-27       Impact factor: 5.191

Review 2.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

Review 3.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 4.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

5.  Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.

Authors:  Xiaoping Qing; Gloria C Koo; Jane E Salmon
Journal:  Eur J Immunol       Date:  2012-06-05       Impact factor: 5.532

6.  Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis.

Authors:  Ruobing Wang; Bao Lu; Craig Gerard; Norma P Gerard
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

Review 7.  Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies.

Authors:  Julian K Horwitz; Nicholas H Chun; Peter S Heeger
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

8.  The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis.

Authors:  Qing Li; Kristine Nacion; Hong Bu; Feng Lin
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

9.  Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis.

Authors:  Fengqi An; Qing Li; Zhidan Tu; Hong Bu; Chi-Chao Chan; Rachel R Caspi; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

10.  Decay accelerating factor is essential for successful corneal engraftment.

Authors:  A Esposito; B Suedekum; J Liu; F An; J Lass; M G Strainic; F Lin; P Heeger; M E Medof
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.